GlaxoSmithKline Cancer Drug Jemperli GSK
GSK’s Jemperli: Awaitng FDA Decision on Expanding Treatment Options. GlaxoSmithKline (GSK)’s immunotherapy drug, Jemperli, is currently under review by the FDA for potential approval in additional cancer indications. The drug … Read More
